Zanubrutinib Outperforms Ibrutinib in Treating Relapsed/Refractory CLL / SLL Mehrdad Mobasher MD Chronic Lymphocytic Leukemia 8 Mins Read4 Zanubrutinib Outperforms Ibrutinib in Treating Relapsed/Refractory CLL/SLL Mehrdad Mobasher MD By Mehrdad Mobasher, MD, MPH The ALPINE study was a…
